Načítá se...
Is intravenous recombinant tissue plasminogen activator (r-tPA) safe in patients on Dabigatran?
INTRODUCTION: Dabigatran etexilate is a newly approved oral anticoagulant indicated for stroke prevention in nonvalvular atrial fibrillation. There are no reliable, rapidly available laboratory markers to assess its anticoagulant activity. There is no data on the safety of r-tPA on patients who are...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Zeenat Qureshi Stroke Research Center
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4051900/ https://ncbi.nlm.nih.gov/pubmed/24920984 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|